Krsnaa Diagnostics Ltd

Auditor appointment

• Appointed M/s Kirtane & Pandit LLP as statutory auditor for five consecutive years.
• Term from 16th AGM conclusion on Sept 28, 2026 to completion of 21st AGM.
• Firm FRN 105215W/W100057 with over seven decades' experience in audit, risk, and tax.
• Approval by members at the 16th AGM held Sept 28, 2026.
• No financial terms or audit fees disclosed.

AGM details

• AGM held on 28 September 2026 at Pune, physical meeting.
• Voting results and Scrutinizer’s report for the AGM enclosed.

Asset sale details

• Board approved sale of identified diagnostic equipment up to ₹120 crore.
• Assets are freehold and not pledged as security.
• Monetisation aligns with asset-light strategy and capital redeployment.
• Terms to be finalised by Operations Committee within the ₹120 crore limit.
• No material adverse impact on P&L or ongoing operations expected.
• Expected ROCE improvement and balance sheet strengthening from asset recycling.

AGM details

• AGM conducted in physical mode in late September 2026.
• Remote e-voting window conducted prior to the meeting.

Resolutions

• Ordinary: Adoption of standalone and consolidated financial statements for the year.
• Ordinary: Final dividend per share proposed/declared.
• Ordinary: Re-appointment of director retiring by rotation.
• Ordinary: Appointment of statutory auditor for five-year term; remuneration to be fixed.
• Ordinary: Ratification of cost auditors' remuneration for the year.

Dividend

• Final dividend per share amount approved.

Directors

• Director retiring by rotation offered for re-appointment.

Auditors

• Statutory auditor appointed for five-year term; remuneration to be fixed.

Krsnaa Diagnostics Ltd: Trading window closed from September 22, 2026 until the expiry of 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ending September 30, 2026

Resolution details

• Special resolution: issue up to 16,21,000 warrants convertible into equity to promoter group.
• Voting outcome: 92.69% in favour, 7.31% against.
• Cut-off date for eligibility: Aug 14, 2026.
• Counterparty: promoter and promoter group; related party transaction.
• Potential capital impact on conversion of warrants to equity.
• Postal ballot concluded Sept 17, 2026.

Concession terms

• Concession with Punjab government via PHSC for 4 PET-CT facilities in Punjab.
• DBFOT PPP model with 15-year concession period.
• Execution completed following August 14, 2026 Letter of Award.
• Revenues will be cash-based and depend on PET-CT scans and user charges.
• Project expands diagnostic services and adds long-term revenue visibility over 15 years.
• No upfront contract value disclosed due to cash-based revenues.
• Locations: four select government hospitals; expansion strengthens government PPP portfolio.
• No related party concerns; awarded by domestic government entity.
• Regulatory approvals completed; all tender formalities satisfied.

AGM notice and annual report access

• AGM: 16th AGM scheduled for September 28, 2026 at 11:00 IST in Pune.
• Annual Report for FY2025-26 and AGM notice dispatched via weblink to unregistered-email shareholders.
• Cut-off date Sept 5, 2026; unregistered emails prevented electronic sending.
• Notice and Annual Report accessible on the company's website.
• Members may vote at the AGM if not previously voted via remote e-voting.
• Shareholders should update KYC details with Depository Participants.

Tax appellate orders and outlook

• Seven appellate orders under Section 250 from CIT(A), Pune for AY 2017-18 to 2023-24.
• Aggregate disputed tax demand across these orders amounts to ₹62,69,17,435.
• AY 2017-18, 2018-19, 2019-20, 2020-21: appeals dismissed at CIT(A).
• AY 2021-22 and 2022-23: appeals partly allowed.
• AY 2023-24: disputed demand ₹6,77,61,887; appeal partly allowed.
• AY 2022-23 rectification reduced payable to ₹31,73,28,734 from ₹19,63,30,624.
• Company intends to file ITAT appeals within timelines and seek relief.
• No impact on ongoing operations; accounting implications to be assessed under applicable standards.